AI CuratorAI-generated

Research summary · 4 h ago

AI summary · not yet reviewedHuman studyAnimal studyLaboratoryPublished in a peer-reviewed journal

Effects on Pericytes in Multiple Sclerosis Models: Impacts on BBB and Neuroinflammation

In laboratory studies involving pericytes from multiple sclerosis (MS) models, significant effects were observed, including suppressed MMP-9 overactivation, reduced neuroinflammation, restoration of pericyte homeostasis, reinforced blood-brain barrier (BBB) integrity, and enhanced myelin repair.

Tags: #MSResearch
Most relevant to: —
Source: Read original source (PMID 42937574)

This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.

Human efficacy: Not established from this source
Mechanism: Not reported
Evidence strength: Limited
Outcome: Not reported

Why it matters

These findings are important as they suggest potential pathways to restore BBB function and mitigate neuroinflammation in MS, highlighting the role of pericytes in MS pathology.

What this does not prove

However, targeted interventions remain lacking, and findings from laboratory models may not fully reflect human MS conditions.

Next milestone

No next milestone was established from the available source.

Study facts

Study design: Laboratory
Participants / samples: Not reported
Randomised: Not reported
Controlled: Not reported
Primary endpoint met: Not reported
Relevant MS type: Not reported
Publication date: 2026-10-27
Evidence reviewed: Abstract only
Regulatory approval: Not reported
Research areas: Not classified
Biological target: Not reported
Pathway: Not reported
Population: Pericytes in MS models
Size of effect: Not reported
Secondary endpoints: Not reported
MRI endpoints: Not reported
Biomarkers: Not reported
Safety: Not reported

Original sources

Primary evidenceTargeting the Immune-Neurovascular Interface to Ameliorate Pericyte Dysfunction with a Multifunctional Peptide-Drug Conjugate Nanoprodrug for Multiple Sclerosis Therapy. ↗DOI: 10.1021/acsnano.6c11475

Supporting passages (7)

study designPublication types: Journal Article

subjectsMeSH terms: Animals; Multiple Sclerosis; Pericytes; Peptides; Prodrugs; Mice; Blood-Brain Barrier; Humans; Encephalomyelitis, Autoimmune, Experimental; Mice, Inbred C57BL; Female

findingsThis system significantly suppressed MMP-9 overactivation and mitigated neuroinflammation.

populationPericyte dysfunction triggers blood-brain barrier (BBB) disruption and subsequent aberrant immune infiltration in multiple sclerosis (MS), yet targeted interventions remain lacking.

publication datePublication date: 2026-10-27

limitationsTitle: Targeting the Immune-Neurovascular Interface to Ameliorate Pericyte Dysfunction with a Multifunctional Peptide-Drug Conjugate Nanoprodrug for Multiple Sclerosis Therapy.

peer reviewedPublication types: Journal Article

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.